The largest database of trusted experimental protocols

Achieva 1.5 tesla

Manufactured by Philips
Sourced in Netherlands

The Achieva 1.5 Tesla is a magnetic resonance imaging (MRI) system manufactured by Philips. It operates at a field strength of 1.5 Tesla, which is a common field strength used in clinical MRI applications. The Achieva 1.5 Tesla is designed to provide high-quality medical imaging for diagnostic purposes.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using achieva 1.5 tesla

1

Cardiac MRI Fibrosis Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cardiac magnetic resonance imaging was performed using a 1.5-T system (Philips Achieva 1.5 Tesla, operating release 2.6 level 3, Philips Healthcare, Netherlands). All CMR exams were reviewed by a single experienced level-3 certified cardiologist who was blinded to the clinical data and myocardial phenotype of the patients. Myocardial fibrosis was quantified using validated software (CVI42, Circle, Canada) as previously described by our group (20 (link)). We set limits for myocardial fibrosis at ≥ 6 SD from the normal myocardium in accordance with published criteria for the assessment of myocardial fibrosis in hypertrophic cardiomyopathy (21 (link), 22 (link)).
+ Open protocol
+ Expand
2

Cardiac MRI Protocol for Fibrosis Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All CMR exams were performed using the same system (Achieva 1.5 Tesla, Philips
Healthcare, Cleveland, OH). A five-element cardiac phased-array coil was used
for signal reception and cardiac synchronization was performed using a vector
electrocardiogram. Cine-CMR images were acquired in 8-10 contiguous short-axis
slices from the level of the mitral valve annulus through the LV apex using a
commercially available steady-state free precession pulse sequence. Technical
parameters were as follows: TR/TE (ms): 3.5/1.8; flip angle: 60°; section
thickness: 8 mm; matrix: 144 x 157; field of view: 320 mm; voxel size: 2.2 x 2.0
mm; and number of phases: 30. For detection of the presence, extent and location
of fibrosis, a breath-hold, T1-weighted, contrast-enhanced inversion-recovery
segmented gradient echo sequence (TR/TE (ms): 4.8/2.3; flip angle: 25°; section
thickness: 10 mm; matrix: 184 x 154; field of view: 320 mm; voxel size: 1.75 x
1.95 mm) was used. These LGE-CMR images were acquired 10 minutes after
intravenous administration of 0.2 mmol/kg of a commercially available gadolinium
chelate of diethylenetriamine pentaacetic acid bismethoxyethylamide
(gadoversetamide, Mallinckrodt, St. Louis, USA), using identical long- and
short-axis planes to the cine images, except for the most apical short-axis
slice, which was excluded because it can be affected by partial-volume
effects.
+ Open protocol
+ Expand
3

Lumbosacral MRI and MRM Imaging Parameters

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cases were examined using the same MRI device (Philips Achieva 1.5 Tesla, Netherland, 2010). During lumbosacral evaluation, MRI and MRM were performed using the following imaging parameters:
(1) Sagittal T1-weighted images: turbo spin echo (TSE) echo time (TE)=8 msec and repetition time (TR)=500 msec.
(2) Sagittal T2-weighted images: TSE TE=100 msec and TR=4,000 msec.
(3) Axial T2-weighted images: TE=120 msec and TR=4,000 msec.
(4) MRM (heavily T2-weighted images): TE=1,000 msec and TR=8,000 msec.
+ Open protocol
+ Expand
4

Neonatal Brain MRI for HIE Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All infants included in the study underwent brain MRI at a median age of 6 days of life. The MRI equipment was a Philips Achieva 1.5 Tesla (Philips Healthcare, Best, Netherlands). The MRI sequence protocol included 3D gradient echo T1-weighted images, gradient echo T2-weighted images, turbo spin echo T2-weighted images, and echo planar diffusion-weighted images. MRI scans were blindly reviewed by an experienced pediatric neuroradiologist, and damage was graded according to the score proposed by Barkovich AJ et al. [19 (link)]. Patients were scored according to damage of basal ganglia, cortical watershed areas, and sum of basal ganglia and watershed damage, and grouped as: “no HIE” if their cumulative score was 0, or “HIE” if their cumulative score was >0.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!